News
The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...
Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 ...
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...
In this July 19, 2022, a vial of Moderna COVID-19 vaccine rests on a table at an inoculation station in Jackson, ...
The new vaccine, mNexspike, is a step toward next-generation coronavirus vaccines. It’s made in a way that allows for a lower ...
The U.S. currently uses five COVID-19 vaccines from Pfizer, Moderna, and Novavax. All are safe and effective against the coronavirus, especially in preventing hospitalization and death.
At a healthcare conference hosted by Goldman Sachs, the CEO of Moderna said front-line workers and people 50 and older may need a fourth dose of the coronavirus vaccine later this year.
Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. The U.S. Food and Drug Administration campus in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results